T. Andrew Kaplan's most recent trade in Kailera Therapeutics Inc. was a trade of 17,857,143 Common Stock done . Disclosure was reported to the exchange on April 16, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Kailera Therapeutics Inc | Andrew T. Kaplan | Director, Ten Percent Owner | 16 Apr 2026 | 17,857,143 | 17,857,143 | - | - | Common Stock | ||
| Kailera Therapeutics Inc | Andrew T. Kaplan | Director, Ten Percent Owner | 16 Apr 2026 | 17,857,143 | 0 | - | - | Series B Preferred Stock | ||
| Kailera Therapeutics Inc | Andrew T. Kaplan | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 16.00 per share. | 16 Apr 2026 | 8,398,438 | 26,255,581 | - | 16 | 134,375,008 | Common Stock |
| Kailera Therapeutics Inc | Andrew T. Kaplan | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Apr 2026 | 38,300 | 38,300 | - | - | Stock Option (right to buy) | |
| Surgery Partners Inc | Andrew T. Kaplan | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 33.44 per share. | 19 Dec 2023 | 7,826,870 | 50,421,379 (100%) | 15% | 33.4 | 261,730,533 | Common Stock |
| Surgery Partners Inc | T. Andrew Kaplan | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 19 Dec 2023 | 474,407 | 49,946,972 (99%) | 0% | 0 | Common Stock |